Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Chickenpox | Research article

Acceptance of universal varicella vaccination among Swiss pediatricians and general practitioners who treat pediatric patients

Authors: Florian Lienert, Olivia Weiss, Kathrin Schmitt, Ulrich Heininger, Patrik Guggisberg

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Over the last two decades, several countries have initiated universal varicella vaccination (UVV) programs in infants. In 2019, the Swiss National Immunization Technical Advisory Group (NITAG) decided to start evaluating the introduction of universal varicella vaccination. There is a theoretical concern that suboptimal vaccination coverage could lead to a shift in the varicella incidence to older age groups, thereby potentially increasing complication rates. To achieve a high vaccination coverage rate, it is important that practicing physicians comply with a potential recommendation for UVV.
We studied the perception of varicella and the current vaccination behavior among Swiss pediatricians and general practitioners (GPs) who treat children. We also assessed their intention to advise parents to vaccinate their children against varicella in the event the Swiss NITAG will recommend UVV.

Methods

Primary data was collected through a structured, 20-min online survey with Swiss pediatricians and GPs who treat children.

Results

150 physicians participated in the study: 40 GPs in the German-speaking part, 20 GPs in the French-speaking part, 67 pediatricians in the German-speaking part, and 23 pediatricians in the French-speaking part.
The majority (64%) of all participants reported that they currently recommend varicella vaccination for risk groups according to the national immunization plan. About one third of physicians (35%) – predominantly pediatricians – currently already recommend it for all infants. In these situations, a measles, mumps, rubella, varicella combination vaccine is currently used by 58% for the first dose and by 59% for the second dose.
86% of participants stated that they would advise parents to have their children vaccinated against varicella in case of a recommendation for UVV by the Swiss NITAG. 68% responded that they expect many questions from parents and 65% agreed that they have good arguments to convey the importance of varicella vaccination.

Conclusions

The survey study results show that most participating pediatricians and GPs indicated a favorable attitude towards childhood vaccination against varicella in the setting of a Swiss NITAG recommendation for UVV. This data shows the importance of NITAG recommendations in influencing vaccine education and supporting achievement of high coverage of varicella vaccination.
Appendix
Available only for authorised users
Literature
3.
go back to reference Bonhoeffer J, Baer G, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr. 2005;164(6):366–70.PubMedCrossRef Bonhoeffer J, Baer G, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr. 2005;164(6):366–70.PubMedCrossRef
4.
go back to reference Bundesamt für Gesundheit, Schweizerischer Impfplan 2020. Bundesamt für Gesundheit, Schweizerischer Impfplan 2020.
5.
go back to reference Bollaerts K, Riera-Montes M, et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol Infect. 2017;145(13):2666–77.PubMedPubMedCentralCrossRef Bollaerts K, Riera-Montes M, et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol Infect. 2017;145(13):2666–77.PubMedPubMedCentralCrossRef
6.
go back to reference Lopez AS, Zhang J, et al. Epidemiology of varicella during the 2-dose varicella vaccination program — United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2016 Sep 2;65(34):902–5.PubMedCrossRef Lopez AS, Zhang J, et al. Epidemiology of varicella during the 2-dose varicella vaccination program — United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2016 Sep 2;65(34):902–5.PubMedCrossRef
7.
go back to reference Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccines Immunother. 2014;10(12):3594–600.CrossRef Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccines Immunother. 2014;10(12):3594–600.CrossRef
8.
go back to reference Spoulou V, Alain S, et al. Implementing universal varicella vaccination in Europe. Pediatr Infect Dis J. 2019;38:181–8.PubMedCrossRef Spoulou V, Alain S, et al. Implementing universal varicella vaccination in Europe. Pediatr Infect Dis J. 2019;38:181–8.PubMedCrossRef
9.
go back to reference Bechini A, Boccalini S, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1):63–71.PubMedCrossRef Bechini A, Boccalini S, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1):63–71.PubMedCrossRef
10.
go back to reference Gil-Prieto R, Walter S, et al. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2014 Jan;32(2):277–83.PubMedCrossRef Gil-Prieto R, Walter S, et al. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2014 Jan;32(2):277–83.PubMedCrossRef
11.
go back to reference Varela FH, Pinto LA, et al. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645–57.PubMedCrossRef Varela FH, Pinto LA, et al. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645–57.PubMedCrossRef
12.
go back to reference Halloran ME, Cochi SL, et al. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol. 1994;140(2):81–104.PubMedCrossRef Halloran ME, Cochi SL, et al. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol. 1994;140(2):81–104.PubMedCrossRef
13.
go back to reference Van Hoek AJ, Melegaro A, et al. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011 Mar 16;29(13):2411–20.PubMedCrossRef Van Hoek AJ, Melegaro A, et al. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011 Mar 16;29(13):2411–20.PubMedCrossRef
15.
go back to reference Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodological). 1995;57(1):289–300.CrossRef Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodological). 1995;57(1):289–300.CrossRef
16.
go back to reference Heininger U. An internet-based survey on parental attitudes towards immunization. Vaccine. 2006;24(37–39):6351–5.PubMedCrossRef Heininger U. An internet-based survey on parental attitudes towards immunization. Vaccine. 2006;24(37–39):6351–5.PubMedCrossRef
17.
go back to reference Paterson P, et al. Vaccine hesitancy and healthcare providers. Vaccine. 2016 Dec 20;34(52):6700–6.PubMedCrossRef Paterson P, et al. Vaccine hesitancy and healthcare providers. Vaccine. 2016 Dec 20;34(52):6700–6.PubMedCrossRef
18.
go back to reference Jenni OG, Sennhauser FH. Child health Care in Switzerland. Child health Care in Switzerland. J Pediatr. 2016;177S:S203–12.PubMedCrossRef Jenni OG, Sennhauser FH. Child health Care in Switzerland. Child health Care in Switzerland. J Pediatr. 2016;177S:S203–12.PubMedCrossRef
19.
go back to reference Charania NA, Watson DG, et al. Perceptions of caregivers and providers regarding the potential introduction of the varicella vaccine to the childhood immunization schedule in New Zealand: a qualitative exploratory study. J Paediatr Child Health. 2018;54:28–35.PubMedCrossRef Charania NA, Watson DG, et al. Perceptions of caregivers and providers regarding the potential introduction of the varicella vaccine to the childhood immunization schedule in New Zealand: a qualitative exploratory study. J Paediatr Child Health. 2018;54:28–35.PubMedCrossRef
20.
21.
go back to reference Rieck T, et al. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccin Immunother. 2014;10(2):476–84.PubMedCrossRef Rieck T, et al. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccin Immunother. 2014;10(2):476–84.PubMedCrossRef
22.
go back to reference IQVIA Solutions. Healthcare Address-Guide (edition February 2020). IQVIA Solutions. Healthcare Address-Guide (edition February 2020).
23.
go back to reference European Centre for Disease Prevention and Control. Varicella vaccination in the European Union. Stockholm: ECDC; 2015. European Centre for Disease Prevention and Control. Varicella vaccination in the European Union. Stockholm: ECDC; 2015.
Metadata
Title
Acceptance of universal varicella vaccination among Swiss pediatricians and general practitioners who treat pediatric patients
Authors
Florian Lienert
Olivia Weiss
Kathrin Schmitt
Ulrich Heininger
Patrik Guggisberg
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05586-3

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue